HOME
ABOUT IASO
Overview
Management Team
Scientific Advisory Board
Partnership
SCIENCE & PRODUCTS
Publictaions
Technology Platforms
Pipeline
Manufacturing
Expanded Access
NEWS
Press Release
Media Report
CAREERS
Growth & Development
Working at IASO
Opportunities
CONTACT
中文简体
中文繁体
English
NEWS
Home
>
Media Report
> Full Article
PRECISIOIN ONCOLOGY NEWS: In Brief This Week-IASO Biotherapeutics, Genentech, BioNTech
2021.08.12
|
IASO，IASO Bio，IASO Biotherapeutics，IASO Biopharma，CT103A， CAR-T， cell therapy，dual-targeted CAR-T
Back
Back
Prev：
Fierce Biotech | China's IASO nets $108M to advance cell therapies, antibodies for cancer, autoimmune disease
Next：
Trailing the Big Pharma players, a lesser known BCMA CAR-T candidate comes into the spotlight
